PLAB:NASDAQPhotronics, Inc. Analysis
Data as of 2026-05-22 - not real-time
$51.06
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Photronics is trading at $51.06, comfortably above its 20‑day ($50.54), 50‑day ($45.26) and 200‑day ($32.33) simple moving averages, indicating a strong bullish price momentum. Volume is increasing and the 30‑day volatility of 54.6% underscores a highly active market. The RSI sits at 55, suggesting the stock is not yet overbought, while the MACD histogram is negative and the signal line is bearish, hinting at a possible short‑term pullback. Support is anchored around $44.88 and resistance near $56, framing the next price corridor. On the fundamentals side, PLAB reports 6.1% year‑over‑year revenue growth, a solid gross margin of 35% and an operating margin of 24%, reflecting resilient profitability. The PE ratio of 21.8 is well below the semiconductor equipment industry average of 39.1, positioning the stock as relatively inexpensive on a earnings basis. However, the discounted cash‑flow fair value of $21.26 is less than half the current price, flagging a substantial valuation gap. The company carries negligible debt (debt‑to‑equity 0.001) and holds $637 M in cash, providing a strong balance sheet. Beta is elevated (computed 3.08, quoted 1.51), indicating heightened sensitivity to market swings. The market sentiment index reads “Extreme Greed” at 90.86, reflecting exuberant investor appetite. Recent news highlights continued semiconductor demand but also notes valuation concerns and a recent insider sale, adding mixed signals to the outlook.
Overall, the stock shows bullish technical signs and solid fundamentals, yet the steep DCF discount and high volatility suggest caution, especially for longer‑term investors.
Overall, the stock shows bullish technical signs and solid fundamentals, yet the steep DCF discount and high volatility suggest caution, especially for longer‑term investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above all major SMAs indicating momentum
- MACD bearish signal suggesting near‑term downside risk
- Increasing volume supporting price stability
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Steady revenue and profit margins
- PE below industry average but DCF fair value far lower than market price
- High beta and volatility exposing the stock to market swings
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- DCF valuation indicates a sizable overprice of current market level
- Sector cyclicality and elevated beta increase downside risk
- Recent insider selling and stretched valuation metrics
Key Metrics & Analysis
Financial Health
Revenue Growth6.10%
Profit Margin15.83%
P/E Ratio21.8
ROE12.22%
ROA7.31%
Debt/Equity0.00
P/B Ratio2.4
Op. Cash Flow$266.6M
Free Cash Flow$36.5M
Industry P/E39.1
Technical Analysis
TrendBullish
RSI55.2
Support$44.88
Resistance$56.00
MA 20$50.54
MA 50$45.26
MA 200$32.33
MACDBearish
VolumeIncreasing
Fear & Greed Index90.86
Valuation
Fair Value$21.26
Target Price$51.50
Upside/Downside0.86%
GradeOvervalued
TypeBlend
Risk Assessment
Beta3.08
Volatility54.56%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.